Published on 20 Jan 2022 on WCTV Tallahassee
ImmPACT Bio Closes $111 Million Series B Financing, Names New Board Chair and New President and CEO,...
ImmPACT Bio USA, Inc. ("ImmPACT Bio"), a clinical-stage company developing transformative logic-gate...
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free